Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Ain-Shams University, Abbassia, Cairo 11566, Egypt.
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Ain-Shams University, Abbassia, Cairo 11566, Egypt.
Spectrochim Acta A Mol Biomol Spectrosc. 2017 Jan 15;171:236-245. doi: 10.1016/j.saa.2016.07.053. Epub 2016 Aug 2.
New, simple, accurate and sensitive UV spectrophotometric and chemometric methods have been developed and validated for determination of Entacapone (ENT), Levodopa (LD) and Carbidopa (CD) in ternary mixture. Method A is a derivative ratio spectra zero-crossing spectrophotometric method which allows the determination of ENT in the presence of both LD and CD by measuring the peak amplitude at 249.9nm in the range of 1-20μgmL. Method B is a double divisor-first derivative of ratio spectra method, used for determination of ENT, LD and CD at 245, 239 and 293nm, respectively. Method C is a mean centering of ratio spectra which allows their determination at 241, 241.6 and 257.1nm, respectively. Methods B and C could successfully determine the studied drugs in concentration ranges of 1-20μgmL for ENT and 10-90μgmL for both LD and CD. Methods D and E are principal component regression and partial least-squares, respectively, used for the simultaneous determination of the studied drugs by using seventeen mixtures as calibration set and eight mixtures as validation set. The developed methods have the advantage of simultaneous determination of the cited components without any pre-treatment. All the results were statistically compared with the reported methods, where no significant difference was observed. The developed methods were satisfactorily applied to the analysis of the investigated drugs in their pure form and in pharmaceutical dosage forms.
已开发和验证了新的、简单的、准确且灵敏的紫外分光光度法和化学计量学法,用于测定三元混合物中的恩他卡朋(ENT)、左旋多巴(LD)和卡比多巴(CD)。方法 A 是导数比光谱零交叉分光光度法,通过在 1-20μgmL 范围内测量 249.9nm 处的峰幅度,允许在存在 LD 和 CD 的情况下测定 ENT。方法 B 是双除数一阶导数比光谱法,分别用于测定 ENT、LD 和 CD 在 245、239 和 293nm 处的含量。方法 C 是比值光谱的均值中心化,分别允许在 241、241.6 和 257.1nm 处测定它们。方法 B 和 C 能够成功地在 1-20μgmL 范围内测定研究药物的 ENT,在 10-90μgmL 范围内测定 LD 和 CD。方法 D 和 E 分别是主成分回归和偏最小二乘法,用于通过使用十七个混合物作为校准集和八个混合物作为验证集同时测定研究药物。所开发的方法具有无需任何预处理即可同时测定引用成分的优点。所有结果均与报道的方法进行了统计学比较,未观察到显著差异。所开发的方法在其纯形式和药物制剂形式的调查药物的分析中得到了令人满意的应用。